NDC 0078-0502 – Exelon
Rivastigmine 9.5 mg/24h · Patch, Extended Release · Transdermal
Product NDC0078-0502
Product details
- Brand name
- Exelon
- Generic name
- Rivastigmine
- Labeler
- Novartis Pharmaceuticals Corporation
- Dosage form
- Patch, Extended Release
- Route
- Transdermal
- Marketing category
- NDA · NDA022083
- Marketed since
- July 6, 2007
- Marketing end
- December 31, 2026
- Pharmacologic class
- Cholinesterase Inhibitor
Active ingredients
- Rivastigmine 9.5 mg/24h
Package NDC codes (1)
| Package NDC | Description | Since |
|---|---|---|
| 0078-0502-15 | 30 PATCH in 1 CARTON (0078-0502-15) / 24 h in 1 PATCH (0078-0502-61) | Jul 6, 2007 |
Other Exelon products
- 0078-0501 Rivastigmine 4.6 mg/24h · Patch, Extended Release · Novartis Pharmaceuticals Corporation
- 0078-0503 Rivastigmine 13.3 mg/24h · Patch, Extended Release · Novartis Pharmaceuticals Corporation
- 66758-142 Rivastigmine 4.6 mg/24h · Patch, Extended Release · Sandoz Inc
- 66758-143 Rivastigmine 9.5 mg/24h · Patch, Extended Release · Sandoz Inc
- 66758-144 Rivastigmine 13.3 mg/24h · Patch, Extended Release · Sandoz Inc